Literature DB >> 19800331

Short peptides derived from the BAG-1 C-terminus inhibit the interaction between BAG-1 and HSC70 and decrease breast cancer cell growth.

Adam Sharp1, Ramsey I Cutress, Peter W M Johnson, Graham Packham, Paul A Townsend.   

Abstract

BAG-1, a multifunctional protein, interacts with a plethora of cellular targets where the interaction with HSC70 and HSP70, is considered vital. Structural studies have demonstrated the C-terminal of BAG-1 forms a bundle of three alpha-helices of which helices 2 and 3 are directly involved in binding to the chaperones. Here we found peptides derived from helices 2 and 3 of BAG-1 interfered with BAG-1:HSC70 binding. We confirmed that a 12 amino-acid peptide from helix 2 directly interacted with HSC70 and when introduced into MCF-7 and ZR-75-1 cells, these peptides inhibited their growth. In conclusion, we have identified a small domain within BAG-1 which appears to play a critical role in the interaction with HSC70.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800331     DOI: 10.1016/j.febslet.2009.09.047

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Gold nanoparticles induce nuclear damage in breast cancer cells, which is further amplified by hyperthermia.

Authors:  Mohamed Kodiha; Eliza Hutter; Sebastien Boridy; Michal Juhas; Dusica Maysinger; Ursula Stochaj
Journal:  Cell Mol Life Sci       Date:  2014-04-17       Impact factor: 9.261

3.  The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells.

Authors:  T J Collard; B C Urban; H A Patsos; A Hague; P A Townsend; C Paraskeva; A C Williams
Journal:  Cell Death Dis       Date:  2012-10-11       Impact factor: 8.469

4.  Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1).

Authors:  Joanna Greenhough; Emmanouil S Papadakis; Ramsey I Cutress; Paul A Townsend; Richard O C Oreffo; Rahul S Tare
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

Review 5.  Chaperone Mediated Autophagy Substrates and Components in Cancer.

Authors:  Javiera Rios; Alvaro Sequeida; Amelina Albornoz; Mauricio Budini
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

6.  BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells.

Authors:  V R Skeen; T J Collard; S L Southern; A Greenhough; A Hague; P A Townsend; C Paraskeva; A C Williams
Journal:  Oncogene       Date:  2012-10-29       Impact factor: 9.867

7.  The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ.

Authors:  E S Papadakis; C R Barker; H Syed; T Reeves; S Schwaiger; H Stuppner; J Troppmair; J P Blaydes; R I Cutress
Journal:  Oncogenesis       Date:  2016-04-04       Impact factor: 7.485

8.  A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells.

Authors:  Emmanouil Papadakis; Natalia Robson; Alison Yeomans; Sarah Bailey; Stephanie Laversin; Stephen Beers; A Emre Sayan; Margaret Ashton-Key; Stefan Schwaiger; Hermann Stuppner; Jakob Troppmair; Graham Packham; Ramsey Cutress
Journal:  Oncotarget       Date:  2016-04-05

Review 9.  BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.

Authors:  E S Papadakis; T Reeves; N H Robson; T Maishman; G Packham; R I Cutress
Journal:  Br J Cancer       Date:  2017-05-16       Impact factor: 7.640

Review 10.  HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy.

Authors:  Alexander E Kabakov; Vladimir L Gabai
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.